Imagine X5RL, a pharmaceutical company, develops a groundbreaking, patented treatment for a widespread chronic disease. X5RL sets a high price on the treatment to recover its R&D costs, fund future innovations, and reap profits. However, many patients – especially in low-income regions — cannot afford the treatment due to lack of – or insufficient – insurance coverage. As a result, a significant measure of the population is foreclosed from the lifesaving treatment.
Discuss!
Post a cohesive, substantive paragraph that incorporates the following ; (do NOT list as a “Q & A”):
· Is the public’s financial issue X5RL’s problem? Should it be?
· How can this company integrate CSR principles into its strategy to profit from its IP and also provide equitable access, and what ethical considerations should guide this approach?
· (HINT: Compare GSK and insulin producers in developing your thoughts).
· In your peer replies, please do not simply find a post to “agree with.” Engage in respectful debate and develop an engaged discussion.
We can handle this paper for you
We Guarantee ZERO Plagiarism ZERO AI
Done by Professional writers from scratch
Leave a Reply